closeButton

COVID-19 Vaccine Tracker

  • Phase 1

    Vaccines in small-scale safety trials

    35

  • Phase 2

    Vaccines in expanded safety trials

    18

  • Phase 3

    Vaccines in large-scale efficacy trials

    25

  • Phase 4

    Vaccines Approved for Other Indications/COVID-19

    4

  • Approved

    Emergency Approval / Limited Use

    9

Sr. No. Phase of Trial Country Condition Product Name Intervention Vaccine Type MOA/Technology Sponsor/Collaborators PRIMARY COMPLETION DATE EXPECTED LAUNCH TRIAL NUMBER TRIAL NAME
1 APPROVED FOR EARLY USE (PHASE 1|PHASE 2) RUSSIA SARS-COV2 EpiVacCorona EpiVacCorona PROTEIN SUBUNIT A PROTEIN FRAGMENT FEDERAL BUDGETARY RESEARCH INSTITUTION STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY "VECTOR" 01-09-2020 Q4 2020 NCT04527575 -
2 APPROVED FOR LIMITED USE (PHASE 3) BRAZIL SARS-COV2 CORONAVAC ADSORBED COVID-19 (INACTIVATED) VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 01-09-2021 Q1 2021 NCT04456595 -
3 APPROVED FOR LIMITED USE (PHASE 3) CHINA COVID-19 - RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) NON REPLICATING VIRAL VECTOR VECTOR VIRUS INSITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA OF CHINA | CANSINO BIOLOGICS INC. | JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION | HUBEI PROVINCIAL CENTER FOR DISEA 31-01-2021 Q1 2021 NCT04341389 CTII-NCOV
4 APPROVED FOR LIMITED USE (PHASE 3) CHINA COVID-19 CORONAVAC INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 28-08-2020 Q1 2021 NCT04383574 -
5 APPROVED FOR LIMITED USE (PHASE 3) CHINA COVID-19 CORONAVAC INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 10-07-2020 Q1 2021 NCT04352608 -
6 APPROVED FOR LIMITED USE (PHASE 3) CHINA COVID-19 CORONAVAC INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 28-08-2020 Q1 2021 NCT04383574 -
7 APPROVED FOR LIMITED USE (PHASE 1 | PHASE 2) CHINA SARS-COV2 BBIBP-CorV INACTIVATED NOVEL CORONAVIRUS (2019-COV) VACCINE (VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) BEIJING INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 28-11-2021 Q1 2021 CHICTR2000032459 -
8 APPROVED FOR EARLY USE (PHASE 1|PHASE 2) RUSSIA SARS-COV2 SPUTNIK V Gam-COVID-Vac NON REPLICATING VIRAL VECTOR VECTOR VIRUS GAMALEYA RESEARCH INSTITUTE 03-08-2020 Q2 2020 NCT04436471 -
9 APPROVED FOR LIMITED USE (PHASE 3) UAE SARS-COV2 - INACTIVATED SARS-COV-2 VACCINE (VERO CELL) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 15-07-2021 Q3 2020 ChiCTR2000034780 -
10 PHASE 4 BRAZIL COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE UNIVERSITY OF CAMPINAS, BRAZIL 01-06-2021 Q4 2021 NCT04369794 -
11 PHASE 4 CHINA COVID-19 - INACTIVATED MYCOBACTERIUM VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE GUANGXI MEDICAL UNIVERSITY 12-12-2022 Q2 2023 ChiCTR2000030016 -
12 PHASE 4 GREECE COVID-19 | VIRUS DISEASES | CORONA VIRUS INFECTION | CORONARY HEART DISEASE | CHRONIC OBSTRUCTIVE PULMONARY DISEASE - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS 25-05-2021 Q4 2021 NCT04414267 ACTIVATE II
13 PHASE 4 USA CORONAVIRUS | CORONAVIRUS INFECTION | CORONAVIRUS AS THE CAUSE OF DISEASES CLASSIFIED ELSEWHERE - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE TEXAS A&M UNIVERSITY | BAYLOR COLLEGE OF MEDICINE | M.D. ANDERSON CANCER CENTER | CEDARS-SINAI MEDICAL CENTER | HARVARD UNIVERSITY 01-05-2021 Q4 2021 NCT04348370 BADAS
14 PHASE 3 AUSTRALIA CORONAVIRUS DISEASE 2019 (COVID-19) | RESPIRATORY ILLNESS | CORONA VIRUS INFECTION | COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE MURDOCH CHILDRENS RESEARCH INSTITUTE | ROYAL CHILDREN'S HOSPITAL 30-06-2021 Q4 2021 NCT04327206 BRACE
15 PHASE 3 BRAZIL SARS-COV2 ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 31-10-2021 Q4 2020 ISRCTN89951424 -
16 PHASE 3 CHINA CORONAVIRUS - RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) PROTEIN SUBUNIT A PROTEIN FRAGMENT ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. 15-09-2021 Q1 2022 NCT04466085 -
17 PHASE 3 COLOMBIA COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE UNIVERSITY OF ANTIOQUIA 01-06-2021 Q4 2021 NCT04362124 -
18 PHASE 3 DENMARK COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE BANDIM HEALTH PROJECT | UNIVERSITY OF SOUTHERN DENMARK 01-01-2021 Q3 2021 NCT04373291 -
19 PHASE 3 EGYPT CORONAVIRUS DISEASE (COVID-19) - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE AIN SHAMS UNIVERSITY 01-10-2020 Q2 2021 NCT04350931 -
20 PHASE 3 EGYPT COVID-19 - MEASLES-MUMPS-RUBELLA VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE KASR EL AINI HOSPITAL 01-10-2020 Q2 2021 NCT04357028 -
21 PHASE 3 FRANCE COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE ASSISTANCE PUBLIQUE - H'PITAUX DE PARIS 11-02-2021 Q4 2021 NCT04384549 -
22 PHASE 3 GERMANY SEVERE RESPIRATORY INFECTIOUS DISEASES IN ELDERLY IN COVID-19 VPM1002 VPM1002 REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE VAKZINE PROJEKT MANAGEMENT GMBH | FGK CLINICAL RESEARCH GMBH 31-05-2021 Q1 2022 NCT04435379 -
23 PHASE 3 GERMANY RESPIRATORY TRACT INFECTION VPM1002 VPM1002 REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE VAKZINE PROJEKT MANAGEMENT GMBH | FGK CLINICAL RESEARCH GMBH 30-06-2021 Q1 2022 NCT04387409 -
24 PHASE 3 INDIA SARS-COV2 COVAXIN INACTIVATED VIRUS WHOLE-VIRION INACTIVATED (COVAXIN) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) BHARAT BIOTECH ; NATIONAL INSTITUTE OF VIROLOGY NA Q2 2021 CTRI/2020/07/026300 -
25 PHASE 3 MEXICO BCG | COVID-19 | SARS-COV2 | CORONA VIRUS INFECTION - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE HOSPITAL UNIVERSITARIO DR. JOSE E. GONZALEZ 01-01-2021 Q4 2021 NCT04461379 -
26 PHASE 3 N/A SARS-COV-2 INFECTION VPM1002 VPM1002 REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE UNIVERSITY HEALTH NETWORK, TORONTO | SERUM INSTITUTE OF INDIA PVT. LTD. | MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY | VERITY PHARMACEUTICALS | BILL GATES FOUNDATION 01-06-2021 Q1 2022 NCT04439045 COBRA
27 PHASE 3 SOUTH AFRICA COVID-19 - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE TASK APPLIED SCIENCE 28-04-2021 Q4 2021 NCT04379336 -
28 PHASE 3 SPAIN COVID-19 | SARS-COV2 RUTI RUTIA VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) PERE-JOAN CARDONA | FUNDACIó INSTITUT GERMANS TRIAS I PUJOL 20-12-2020 Q3 2021 NCT04453488 -
29 PHASE 3 USA SARS-COV-2 PittCoVacc MRNA-1273 GENETIC VACCINE A PROTEIN FRAGMENT MODERNATX, INC. | BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) 27-10-2022 Q4 2020 NCT04470427 -
30 PHASE 3 USA SARS-COV-2 MRNA-1273 MRNA-1273 GENETIC VACCINE A PROTEIN FRAGMENT MODERNATX, INC. | BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY 01-08-2021 Q2 2021 NCT04405076 -
31 PHASE 3 USA SARS-COV 2 | VIRAL INFECTION | COVID 19 JNJ-78436735 (Ad26.COV2-S) Ad26.COV2.S NON REPLICATING VIRAL VECTOR VECTOR VIRUS JANSSEN VACCINES & PREVENTION B.V. 15-09-2021 Q2 2021 NCT04436276 -
32 PHASE 2B| PHASE 3 GERMANY COVID-2019 BNT162 BNT162A1, BNT162B1, BNT162B2, BNT162C2 RNA VACCINE A PROTEIN FRAGMENT BIONTECH RNA PHARMACEUTICALS GMBH | BIONTECH SE 01-11-2020 Q4 2020 NCT04380701 -
33 PHASE 2B| PHASE 3 UNITED KINGDOM SARS-COV2 AZD1222, ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 01-08-2021 Q4 2020 2020-001228-32 -
34 PHASE 2B| PHASE 3 UNITED KINGDOM CORONAVIRUS AZD1222, ChAdOx1 nCoV-19 CHADOX1 NCOV-19 (ABS 260), MENACWY VACCINE, CHADOX1 NCOV-19 (ABS 260) + 2.2X10^10VP (QPCR) BOOST, TWO DOSE MENACWY VACCINE, CHADOX1 N-COV-19 (ABS 260) VACCINE LOW DOSE, CHADOX1 NCOV-19 (QPCR), CHADOX1 NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD 01-08-2021 Q4 2020 NCT04400838 -
35 PHASE 2B| PHASE 3 UNITED KINGDOM CORONAVIRUS AZD1222, ChAdOx1 nCoV-19, COVISHIELD CHADOX1 NCOV-19,MENACWY,CHADOX1 NCOV-19 FULL BOOST,CHADOX1 NCOV-19 HALF BOOST,MENACWY BOOST,PARACETAMOL NON REPLICATING VIRAL VECTOR VECTOR VIRUS THE UNIVERSITY OF OXFORD |'ASTRAZENECA | IQVIA | SERUM INSTITUTE OF INDIA 01-05-2021 Q4 2020 NCT04324606 -
36 PHASE 2B| PHASE 3 UNITED KINGDOM SARS-COV2 AZD1222, ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 01-05-2021 Q4 2020 PACTR202006922165132, 2020-001072-15 -
37 PHASE 2B| PHASE 3 USA SARS-COV-2 INFECTION | COVID-19 BNT162 BNT162A1, BNT162B1, BNT162B2, BNT162C2 RNA VACCINE A PROTEIN FRAGMENT BIONTECH SE | PFIZER 19-04-2021 Q4 2020 NCT04368728 -
38 PHASE 2| PHASE 3 GERMANY SARS-COV2 BNT162 3 LNP-MRNAS RNA VACCINE A PROTEIN FRAGMENT BIONTECH | FOSUN PHARMA |PFIZER 01-10-2020 Q4 2020 2020-001038-36 -
39 PHASE 2 CHINA SARS-COV2 - INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WEST CHINA SECOND UNIVERSITY HOSPITAL | YUNNAN CENTER FOR DISEASE CONTROL AND PREVENTION | CHINESE ACADEMY OF MEDICAL SCIENCES 01-09-2020 Q2 2021 NCT04412538 -
40 PHASE 2 CHINA SARS-COV2 2019-nCOV RECOMBINANT NOVEL CORONAVIRUS (2019-NCOV) VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICAL INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY 31-01-2021 Q3 2021 CHICTR2000031781 -
41 PHASE 2 CHINA CORONAVIRUS - RECOMBINANT NEW CORONAVIRUS VACCINE (Sf9 CELL) PROTEIN SUBUNIT A PROTEIN FRAGMENT WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY 16-11-2021 Q1 2022 ChiCTR2000039994 -
42 PHASE 2 GERMANY COVID-19 CVnCoV CVnCoV RNA VACCINE A PROTEIN FRAGMENT CUREVAC 01-11-2021 Q2 2021 NCT04515147 -
43 PHASE 2 INDIA SARS-COV2 ZYCOV-D DNA-BASED DNA PLASMID (ZYCOV-D) DNA VACCINE A PROTEIN FRAGMENT ZYDUS CADILA HEALTHCARE LIMITED NA Q2 2021 CTRI/2020/07/026352 -
44 PHASE 2 UNITED KINGDOM SARS-COV2 SNG001 INTERFERON BETA (IFN-') PROTEIN SUBUNIT A PROTEIN FRAGMENT SYNAIRGEN RESEARCH LTD. 01-02-2021 Q2 2021 NCT04385095 -
45 PHASE 2 USA CORONAVIRUS INFECTION INO-4800 INO-4800, DEVICE: CELLECTRA' 200 DNA VACCINE A PROTEIN FRAGMENT INOVIO PHARMACEUTICALS | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) 01-07-2021 Q2 2021 NCT04336410 -
46 PHASE 2 USA CORONAVIRUS INFECTION | SARS-COV 2 INO-4800 INO-4800, DEVICE: CELLECTRA' 200 DNA VACCINE A PROTEIN FRAGMENT INTERNATIONAL VACCINE INSTITUTE | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS | INOVIO PHARMACEUTICALS 22-02-2022 Q1 2022 NCT04447781 -
47 PHASE 1B| PHASE 2B CHINA COVID-19 - INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) CHINESE ACADEMY OF MEDICAL SCIENCES | WEST CHINA SECOND UNIVERSITY HOSPITAL | YUNNAN CENTER FOR DISEASE CONTROL AND PREVENTION 01-11-2020 Q2 2021 NCT04470609 -
48 PHASE 1 B|PHASE 2 USA COVID-19 AV-COVID-19 AV-COVID-19 NOT STATED N/A AIVITA BIOMEDICAL, INC. 01-12-2020 Q2 2021 NCT04386252 -
49 PHASE 1 | PHASE 2 AUSTRALIA SARS-COV2 NVX-CoV2373 FULL LENGTH RECOMBINANT SARS COV-2 GLYCOPROTEIN NANOPARTICLE VACCINE ADJUVANTED WITH MATRIX M PROTEIN SUBUNIT A PROTEIN FRAGMENT NOVAVAX 01-12-2020 Q1 2021 NCT04368988 -
50 PHASE 1|PHASE 2 CANADA COVID-19 - V-SARS INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) IMMUNITOR LLC 15-05-2021 Q4 2021 NCT04380532 -
51 PHASE 1|PHASE 2 CHINA PATHOGEN INFECTION COVID-19 INFECTION SYNTHETIC MINIGENE VACCINE LV-SMENP-DC VACCINE AND ANTIGEN-SPECIFIC CTLS RNA VACCINE A PROTEIN FRAGMENT SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE | SHENZHEN THIRD PEOPLE'S HOSPITAL | SHENZHEN SECOND PEOPLE'S HOSPITAL 31-07-2023 Q4 2024 NCT04276896 -
52 PHASE 1|PHASE 2 CUBA SARS-COV-2 CORONAVIRUS SOBERANA 01 RBD SPIKE PROTEIN PROTEIN SUBUNIT A PROTEIN FRAGMENT FINLAY VACCINE INSTITUTE 11-01-2021 Q2 2021 NA -
53 PHASE 1|PHASE 2 INDIA COVID19 | SARS-COV INFECTION BBV152 BBV152A, BBV152B, BBV152C INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) BHARAT BIOTECH INTERNATIONAL LIMITED | INDIAN COUNCIL OF MEDICAL RESEARCH 30-06-2021 Q1 2021 NCT04471519 BBV152
54 PHASE 1|PHASE 2 JAPAN SARS-COV2 AG0301-COVID19 AG0301-COVID19 DNA VACCINE A PROTEIN FRAGMENT OSAKA UNIVERSITY | ANGES | TAKARA BIO 26-09-2020 Q2 2021 NCT04463472, JapicCTI-205328 -
55 PHASE 1|PHASE 2 KOREA SARS-COV2 GX-19 DNA VACCINE (GX-19) DNA VACCINE A PROTEIN FRAGMENT GENEXINE CONSORTIUM 17-03-2021 Q1 2021 NCT04445389 -
56 PHASE 1|PHASE 2 SINGAPORE COVID-19 LUNAR-COV19 LUNAR-COV19 RNA VACCINE A PROTEIN FRAGMENT ARCTURUS THERAPEUTICS AND DUKENUS 01-12-2020 Q3 2021 NCT04480957 -
57 PHASE 1|PHASE 2 SOUTH AFRICA CORONAVIRUS AZD1222 CHADOX1 NCOV-19 NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF WITWATERSRAND, SOUTH AFRICA | MEDICAL RESEARCH COUNCIL, SOUTH AFRICA | BILL AND MELINDA GATES FOUNDATION | UNIVERSITY OF OXFORD 01-10-2020 Q4 2020 NCT04444674 -
58 PHASE 1|PHASE 2 UNITED KINGDOM | FRANCE SARS-COV-2 INFECTION | COVID-19 - RECOMBINANT PROTEIN-BASED VACCINE RNA VACCINE A PROTEIN FRAGMENT SANOFI | GSK 01-11-2020 Q2 2021 NCT04537208 -
59 PHASE 1 | PHASE 2 CANADA COVID-19 Ad5-nCoV RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICS INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY | CANADIAN CENTER FOR VACCINOLOGY 30-12-2021 Q1 2022 NCT04398147 -
60 PHASE 1 | PHASE 2 CHINA SARS-COV2 - INACTIVATED NOVEL CORONAVIRUS PNEUMONIA VACCINE (VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 11-10-2021 Q1 2021 CHICTR2000031809 -
61 PHASE 1 | PHASE 2 KAZAKHSTAN COVID-19 QazCovid-in' QazCovid-in' INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS | NATIONAL SCIENTIFIC CENTER FOR PHTHISIOPULMONOLOGY OF THE REPUBLIC OF KAZAKHSTAN 31-12-2020 Q1 2021 NCT04530357 -
62 PHASE 1 | PHASE 2 UNITED KINGDOM SARS-COV2 COVAC1 LNP-NCOVSARNA RNA VACCINE A PROTEIN FRAGMENT IMPERIAL COLLEGE LONDON 31-07-2021 Q1 2022 ISRCTN17072692 ; 2020-001646-20 COVAC1
63 PHASE 1 | PHASE 2 USA SARS-COV2 KBP-COVID-19 KBP-COVID-19 (RBD-based vaccine) PROTEIN SUBUNIT A PROTEIN FRAGMENT KENTUCKY BIOPROCESSING, INC 25-01-2021 Q4 2021 NCT04473690 -
64 PHASE 1 AUSTRALIA SARS-COV2 - HEPATITIS B SURFACE ANTIGEN (HBSAG) VIRUS LIKE PARTICLE (VLP) VIRUS LIKE PARTICLES BIOSYNTHETIC VIRUS SPYBIOTECH | SERUM INSTITUTE OF INDIA PVT LTD 30-03-2021 Q1 2022 ACTRN12620000817943 -
65 PHASE 1 AUSTRALIA SARS-COV2 SCB-2019 SCB-2019 PROTEIN SUBUNIT A PROTEIN FRAGMENT CLOVER BIOPHARMACEUTICALS AUS PTY LTD | GLAXOSMITHKLINE | 'SANOFI 20-10-2020 Q4 2021 NCT04405908 -
66 PHASE 1 AUSTRALIA SARS-COV2 - MOLECULAR CLAMP STABILIZED SPIKE PROTEIN WITH MF59 ADJUVANT PROTEIN SUBUNIT A PROTEIN FRAGMENT UNIVERSITY OF QUEENSLAND | CSL |SEQIRUS NA Q2 2021 ACTRN12620000674932 -
67 PHASE 1 AUSTRALIA CORONAVIRUS INFECTION | COVID COVAX-19 COVID19 VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT VAXINE PTY LTD | CENTRAL ADELAIDE LOCAL HEALTH NETWORK INCORPORATED 01-07-2020 Q1 2021 NCT04453852 COVAX-19
68 PHASE 1 BELGIUM | FRANCE CORONAVIRUS DISEASE (COVID-19) TMV-083 TMV-083 NON REPLICATING VIRAL VECTOR VECTOR VIRUS INSTITUT PASTEUR | THEMIS BIOSCIENCE GMBH | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS 01-11-2020 Q1 2022 NCT04497298 -
69 PHASE 1 CANADA SARS-COV 2 - CORONAVIRUS-LIKE PARTICLE COVID-19 VACCINE (PLANT DERIVED VLP) VIRUS LIKE PARTICLES BIOSYNTHETIC VIRUS MEDICAGO;'GSK;'DYNAVAX 30-04-2021 Q4 2021 NCT04450004 -
70 PHASE 1 CANADA COVID-19 - bacTRL-Spike DNA VACCINE A PROTEIN FRAGMENT SYMVIVO CORPORATION 31-08-2021 Q2 2021 NCT04334980 -
71 PHASE 1 CANADA COVID-19 Covigenix VAX-001 PLASMID DNA VACCINE DNA VACCINE A PROTEIN FRAGMENT ENTOS PHARMACEUTICALS INC. 01-06-2021 Q4 2021 NCT04591184 -
72 PHASE 1 CUBA COVID-19 SOBERANA 1 PROTEINS FROM A BACTERIA PROTEIN SUBUNIT A PROTEIN FRAGMENT FINLAY VACCINE INSTITUTE 30-10-2020 Q4 2021 IFV/COR/04 -
73 PHASE 1 CHINA COVID-19 - INACTIVATED SARS-COV-2 VACCINE(VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) LI GUIFAN 02-10-2020 Q4 2021 CHICTR2000038804 -
74 PHASE 1 CHINA COVID-19 Ad5-nCoV RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICS INC. | INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES. PLA OF CHINA | JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION | HUBEI PROVINCIAL CENTER FOR DISE 30-12-2020 Q2 2021 NCT04313127 CTCOVID-19
75 PHASE 1 CHINA SARS-COV2 2019-COV RECOMBINANT NOVEL CORONAVIRUS (2019-COV) VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT CANSINO BIOLOGICAL INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY 01-12-2020 Q2 2021 CHICTR2000030906 -
76 PHASE 1 CHINA SARS-COV-2 INFECTION | COVID-19 BNT162b1 BNT162b1 RNA VACCINE A PROTEIN FRAGMENT JIANGSU PROVINCIAL CENTER FOR DISEASE PREVENTION AND CONTROL 01-08-2020 Q1 2021 ChiCTR2000034825 -
77 PHASE 1 CHINA CORONAVIRUS - RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) PROTEIN SUBUNIT A PROTEIN FRAGMENT ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. | THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY | BEIJING CHAO YANG HOSPITAL 21-07-2021 Q4 2021 NCT04445194 -
78 PHASE 1 CHINA COVID-19 INFECTION - PATHOGEN-SPECIFIC AAPC RNA VACCINE A PROTEIN FRAGMENT SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE | SHENZHEN THIRD PEOPLE'S HOSPITAL | SHENZHEN SECOND PEOPLE'S HOSPITAL 31-07-2023 Q4 2024 NCT04299724 -
79 PHASE 1 CHINA SARS-COV2 - RNA-BASED VACCINE MRNA RNA VACCINE A PROTEIN FRAGMENT PEOPLE'S LIBERATION ARMY (PLA) ACADEMY OF MILITARY SCIENCES | WALVAX BIOTECH 31-12-2021 Q2 2022 CHICTR2000034112 -
80 PHASE 1 CHINA COVID-19 - MicroRNA2911 RNA VACCINE A PROTEIN FRAGMENT IMMUNITOR LLC 31-08-2020 Q3 2021 ChiCTR2000031432 -
81 PHASE 1 GERMANY COVID-19 GRAD-COV2 GORILLA-DERIVED REPLICATION-DEFECTIVE ADENOVIRAL VECTOR PROTEIN SUBUNIT A PROTEIN FRAGMENT REITHERA | LEUKOCARE 01-12-2021 Q1 2021 NA -
82 PHASE 1 GERMANY SEVERE ACUTE RESPIRATORY SYNDROME | CORONAVIRUS | SARS-COV-2 | COVID-19 CVnCoV CVNCOV VACCINE RNA VACCINE A PROTEIN FRAGMENT CUREVAC AG | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) 01-08-2021 Q2 2021 NCT04449276 -
83 PHASE 1 GERMANY COVID-19 - MULTIPEPTIDE COCKTAIL PROTEIN SUBUNIT A PROTEIN FRAGMENT UNIVERSITY OF TU'BINGEN 30-09-2021 Q2 2022 NCT04546841 -
84 PHASE 1 GERMANY COVID-19 MVA-SARS-2-S MVA-SARS-2-S PROTEIN SUBUNIT A PROTEIN FRAGMENT GERMAN CENTER FOR INFECTION RESEARCH | UNIVERSIT'TSKLINIKUM HAMBURG-EPPENDORF 01-05-2021 Q4 2021 NCT04569383 -
85 PHASE 1 ISRAEL COVID-19 BRILIFE VESICULAR STOMATITIS VIRUSES PROTEIN SUBUNIT A PROTEIN FRAGMENT ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH 01-11-2021 Q2 2022 NA -
86 PHASE 1 NOT STATED COVID COVAX-19 COVAX-19 PROTEIN SUBUNIT A PROTEIN FRAGMENT GENECURE BIOTECHNOLOGIES 01-07-2021 Q1 2022 NCT04428073 -
87 PHASE 1 TAIWAN COVID-19 AdimrSC-2f AdimrSC-2f PROTEIN SUBUNIT A PROTEIN FRAGMENT ADIMMUNE CORPORATION 20-11-2020 Q4 2021 NCT04522089 -
88 PHASE 1 TAIWAN COVID-19 MVC-COV1901 MVC-COV1901 PROTEIN SUBUNIT A PROTEIN FRAGMENT MEDIGEN VACCINE BIOLOGICS CORP. 30-05-2021 Q4 2021 NCT04487210 -
89 PHASE 1 TAIWAN COVID-19 UB-612 UB-612 PROTEIN SUBUNIT A PROTEIN FRAGMENT COVAXX | UNITED BIOMEDICAL INC., ASIA 31-12-2020 Q1 2021 NCT04545749 -
90 PHASE 1 THAILAND SARS-COV2 ChulaCov19 RNA-BASED VACCINE MRNA RNA VACCINE A PROTEIN FRAGMENT CHULA VACCINE RESEARCH CENTER | CHULALONGKORN UNIVERSITY 01-03-2021 Q3 2021 NCT04566276 -
91 PHASE 1 TURKEY SARS-COV2 ERUCOV-VAC INACTIVE VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) ERCIYES UNIVERSITY | KOCAK PHARMA NA Q1 2022 NA -
92 PHASE 1 UNITED KINGDOM COVID-19 COVI-VAC COVI-VAC INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) CODAGENIX, INC 01-06-2021 Q1 2022 NCT04619628 -
93 PHASE 1 USA COVID-19 | COVID-19 IMMUNISATION MRNA-1273 MRNA-1273 RNA VACCINE A PROTEIN FRAGMENT NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) 22-11-2021 Q2 2021 NCT04283461 -
94 PHASE 1 USA COVID-19 VXA-CoV2-1 VXA-CoV2-1 NON REPLICATING VIRAL VECTOR VECTOR VIRUS VAXART 01-12-2020 Q2 2021 NCT04563702 -
95 PHASE 1 USA COVID-19 - hAd5-S-FUSION+N-ETSD VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT IMMUNITYBIO, INC. 19-11-2021 Q2 2022 NCT04591717 -
96 PHASE 1 USA CORONAVIRUS DISEASE (COVID-19) V591 V591 NON REPLICATING VIRAL VECTOR VECTOR VIRUS MERCK SHARP & DOHME CORP. 26-04-2022 Q3 2022 NCT04498247 V591-001
97 PHASE 1 USA CORONAVIRUS DISEASE (COVID-19) V590 V590 NON REPLICATING VIRAL VECTOR VECTOR VIRUS MERCK SHARP & DOHME CORP. 03-12-2021 Q1 2022 NCT04569786 V590-001
98 PHASE 1 USA SARS-CoV-2 CORVax SPIKE (S) PROTEIN PLASMID DNA DNA VACCINE A PROTEIN FRAGMENT PROVIDENCE HEALTH & SERVICES | ONCOSEC IMMUNOTHERAPIES 01-05-2021 Q4 2021 NCT04627675 -
Get In Touch

To request for sample data or to subscribe, kindly fill this form.